Literature DB >> 26268608

Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion.

Dayana B Rivadeneira1, M Cecilia Caino1, Jae Ho Seo1, Alessia Angelin2, Douglas C Wallace2, Lucia R Languino3, Dario C Altieri4.   

Abstract

Survivin promotes cell division and suppresses apoptosis in many human cancers, and increased abundance correlates with metastasis and poor prognosis. We showed that a pool of survivin that localized to the mitochondria of certain tumor cell lines enhanced the stability of oxidative phosphorylation complex II, which promoted cellular respiration. Survivin also supported the subcellular trafficking of mitochondria to the cortical cytoskeleton of tumor cells, which was associated with increased membrane ruffling, increased focal adhesion complex turnover, and increased tumor cell migration and invasion in cultured cells, and enhanced metastatic dissemination in vivo. Therefore, we found that mitochondrial respiration enhanced by survivin contributes to cancer metabolism, and relocalized mitochondria may provide a "regional" energy source to fuel tumor cell invasion and metastasis.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26268608      PMCID: PMC4539531          DOI: 10.1126/scisignal.aab1624

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  55 in total

Review 1.  The axonal transport of mitochondria.

Authors:  William M Saxton; Peter J Hollenbeck
Journal:  J Cell Sci       Date:  2012-05-22       Impact factor: 5.285

2.  Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.

Authors:  Young Chan Chae; M Cecilia Caino; Sofia Lisanti; Jagadish C Ghosh; Takehiko Dohi; Nika N Danial; Jessie Villanueva; Stefano Ferrero; Valentina Vaira; Luigi Santambrogio; Silvano Bosari; Lucia R Languino; Meenhard Herlyn; Dario C Altieri
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

Review 3.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility.

Authors:  Jianxiu Yu; Dongyun Zhang; Jinyi Liu; Jingxia Li; Yonghui Yu; Xue-Ru Wu; Chuanshu Huang
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

5.  IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation.

Authors:  Tripat Kaur Oberoi; Taner Dogan; Jennifer C Hocking; Rolf-Peter Scholz; Juliane Mooz; Carrie L Anderson; Christiaan Karreman; Dagmar Meyer zu Heringdorf; Gudula Schmidt; Mika Ruonala; Kazuhiko Namikawa; Gregory S Harms; Alejandro Carpy; Boris Macek; Reinhard W Köster; Krishnaraj Rajalingam
Journal:  EMBO J       Date:  2011-11-25       Impact factor: 11.598

Review 6.  Targeting IAP proteins for therapeutic intervention in cancer.

Authors:  Simone Fulda; Domagoj Vucic
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

Review 7.  Survivin in solid tumors: rationale for development of inhibitors.

Authors:  David N Church; Denis C Talbot
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

8.  Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis.

Authors:  Congying Wu; Sreeja B Asokan; Matthew E Berginski; Elizabeth M Haynes; Norman E Sharpless; Jack D Griffith; Shawn M Gomez; James E Bear
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

9.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.

Authors:  Sevin Turcan; Daniel Rohle; Anuj Goenka; Logan A Walsh; Fang Fang; Emrullah Yilmaz; Carl Campos; Armida W M Fabius; Chao Lu; Patrick S Ward; Craig B Thompson; Andrew Kaufman; Olga Guryanova; Ross Levine; Adriana Heguy; Agnes Viale; Luc G T Morris; Jason T Huse; Ingo K Mellinghoff; Timothy A Chan
Journal:  Nature       Date:  2012-02-15       Impact factor: 69.504

10.  Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.

Authors:  Michalina Janiszewska; Mario L Suvà; Nicolo Riggi; Riekelt H Houtkooper; Johan Auwerx; Virginie Clément-Schatlo; Ivan Radovanovic; Esther Rheinbay; Paolo Provero; Ivan Stamenkovic
Journal:  Genes Dev       Date:  2012-08-16       Impact factor: 11.361

View more
  45 in total

Review 1.  Immunometabolism: Cellular Metabolism Turns Immune Regulator.

Authors:  Róisín M Loftus; David K Finlay
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

Review 2.  Mitochondrial dynamics as regulators of cancer biology.

Authors:  Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

3.  NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.

Authors:  Oded Bergman; Rachel Karry; Jumana Milhem; Dorit Ben-Shachar
Journal:  Mol Psychiatry       Date:  2018-12-10       Impact factor: 15.992

Review 4.  Survivin at a glance.

Authors:  Sally P Wheatley; Dario C Altieri
Journal:  J Cell Sci       Date:  2019-04-04       Impact factor: 5.285

5.  Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer.

Authors:  Maria J Fernández-Cabezudo; Issam Faour; Kenneth Jones; Devin P Champagne; Mohammed A Jaloudi; Yassir A Mohamed; Ghada Bashir; Saeeda Almarzooqi; Alia Albawardi; M Jawad Hashim; Thomas S Roberts; Haytham El-Salhat; Hakam El-Taji; Adnan Kassis; Dylan E O'Sullivan; Brock C Christensen; James DeGregori; Basel K Al-Ramadi; Mercedes Rincon
Journal:  JCI Insight       Date:  2016-05-19

Review 6.  Metabolic regulation of immune responses: therapeutic opportunities.

Authors:  Nadine Assmann; David K Finlay
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

7.  Correlation between Survivin expression and laryngeal carcinoma: A meta-analysis.

Authors:  Juan Geng; Yan-Rong Lei; Sheng-Guang Pei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 8.  Mitochondrial dynamics and metastasis.

Authors:  Dario C Altieri
Journal:  Cell Mol Life Sci       Date:  2018-11-10       Impact factor: 9.261

9.  Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.

Authors:  Olivier Boucherat; Thibaut Peterlini; Alice Bourgeois; Valérie Nadeau; Sandra Breuils-Bonnet; Stéphanie Boilet-Molez; François Potus; Jolyane Meloche; Sophie Chabot; Caroline Lambert; Eve Tremblay; Young Chan Chae; Dario C Altieri; Gopinath Sutendra; Evangelos D Michelakis; Roxane Paulin; Steeve Provencher; Sébastien Bonnet
Journal:  Am J Respir Crit Care Med       Date:  2018-07-01       Impact factor: 21.405

Review 10.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.